Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arsenic | 109 | 2023 | 251 | 19.790 |
Why?
|
Water Pollutants, Chemical | 57 | 2022 | 135 | 11.750 |
Why?
|
Environmental Exposure | 77 | 2023 | 296 | 11.690 |
Why?
|
Arsenic Poisoning | 38 | 2023 | 103 | 8.760 |
Why?
|
Bangladesh | 136 | 2023 | 318 | 8.480 |
Why?
|
Drinking Water | 28 | 2023 | 64 | 7.110 |
Why?
|
Skin Diseases | 23 | 2019 | 166 | 5.750 |
Why?
|
Water Supply | 30 | 2021 | 60 | 4.530 |
Why?
|
Polymorphism, Single Nucleotide | 52 | 2023 | 2357 | 3.970 |
Why?
|
Genetic Predisposition to Disease | 50 | 2024 | 2271 | 3.670 |
Why?
|
Genome-Wide Association Study | 36 | 2024 | 1621 | 3.440 |
Why?
|
Breast Neoplasms | 34 | 2024 | 2903 | 3.000 |
Why?
|
Cardiovascular Diseases | 23 | 2023 | 827 | 2.950 |
Why?
|
Smoking | 25 | 2020 | 609 | 2.730 |
Why?
|
Diet | 13 | 2019 | 443 | 2.580 |
Why?
|
Middle Aged | 158 | 2024 | 25028 | 2.530 |
Why?
|
Longitudinal Studies | 48 | 2023 | 1019 | 2.510 |
Why?
|
Adult | 149 | 2024 | 25648 | 2.480 |
Why?
|
Cohort Studies | 58 | 2024 | 2767 | 2.440 |
Why?
|
Female | 206 | 2024 | 44532 | 2.420 |
Why?
|
DNA Methylation | 25 | 2023 | 628 | 2.370 |
Why?
|
Risk Factors | 85 | 2024 | 5417 | 2.370 |
Why?
|
Dyspnea | 5 | 2017 | 73 | 2.330 |
Why?
|
Humans | 290 | 2024 | 86643 | 2.300 |
Why?
|
Arsenicals | 13 | 2023 | 48 | 2.280 |
Why?
|
Male | 183 | 2023 | 40965 | 2.280 |
Why?
|
Prospective Studies | 61 | 2024 | 4213 | 2.230 |
Why?
|
Precancerous Conditions | 7 | 2010 | 196 | 1.940 |
Why?
|
Body Mass Index | 20 | 2023 | 770 | 1.840 |
Why?
|
Genotype | 27 | 2019 | 1851 | 1.640 |
Why?
|
Water Pollution, Chemical | 8 | 2015 | 21 | 1.600 |
Why?
|
Quantitative Trait Loci | 5 | 2022 | 576 | 1.580 |
Why?
|
Selenium | 9 | 2019 | 44 | 1.560 |
Why?
|
Genome, Human | 11 | 2019 | 756 | 1.500 |
Why?
|
Mortality | 7 | 2021 | 149 | 1.490 |
Why?
|
Aged | 78 | 2023 | 18415 | 1.440 |
Why?
|
Case-Control Studies | 39 | 2023 | 1805 | 1.440 |
Why?
|
Neoplasms | 20 | 2023 | 2898 | 1.430 |
Why?
|
Gene-Environment Interaction | 5 | 2018 | 103 | 1.420 |
Why?
|
Methyltransferases | 7 | 2023 | 182 | 1.410 |
Why?
|
Oryza | 4 | 2019 | 40 | 1.400 |
Why?
|
Young Adult | 41 | 2023 | 5976 | 1.400 |
Why?
|
Food Contamination | 4 | 2019 | 31 | 1.390 |
Why?
|
Carotid Intima-Media Thickness | 9 | 2018 | 38 | 1.380 |
Why?
|
Adolescent | 44 | 2022 | 8981 | 1.340 |
Why?
|
Lung Diseases | 3 | 2016 | 263 | 1.310 |
Why?
|
Colorectal Neoplasms | 9 | 2024 | 938 | 1.290 |
Why?
|
Antioxidants | 4 | 2013 | 223 | 1.260 |
Why?
|
Vitamin B Complex | 7 | 2010 | 21 | 1.230 |
Why?
|
Rural Population | 12 | 2023 | 136 | 1.230 |
Why?
|
Cross-Sectional Studies | 36 | 2023 | 1621 | 1.230 |
Why?
|
Telomere | 9 | 2021 | 108 | 1.210 |
Why?
|
Proteinuria | 3 | 2015 | 107 | 1.210 |
Why?
|
Thinness | 5 | 2022 | 43 | 1.160 |
Why?
|
Genotyping Techniques | 2 | 2017 | 68 | 1.110 |
Why?
|
Proportional Hazards Models | 17 | 2024 | 859 | 1.110 |
Why?
|
Dietary Proteins | 3 | 2012 | 30 | 1.100 |
Why?
|
Blood Pressure | 11 | 2022 | 1143 | 1.100 |
Why?
|
Prevalence | 19 | 2024 | 1239 | 1.090 |
Why?
|
Folic Acid | 9 | 2019 | 60 | 1.090 |
Why?
|
Diabetes Mellitus, Type 2 | 8 | 2024 | 1373 | 1.060 |
Why?
|
Biomarkers, Tumor | 9 | 2018 | 1464 | 1.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 9 | 2017 | 689 | 1.020 |
Why?
|
Keratosis | 4 | 2012 | 21 | 1.010 |
Why?
|
Food | 3 | 2015 | 86 | 0.990 |
Why?
|
Microsatellite Instability | 1 | 2024 | 43 | 0.950 |
Why?
|
Environmental Monitoring | 9 | 2019 | 71 | 0.950 |
Why?
|
Heart Diseases | 3 | 2016 | 290 | 0.950 |
Why?
|
Genetic Variation | 10 | 2022 | 1351 | 0.950 |
Why?
|
Odds Ratio | 19 | 2019 | 678 | 0.910 |
Why?
|
Pancreatic Neoplasms | 4 | 2013 | 645 | 0.890 |
Why?
|
Incidence | 15 | 2024 | 1577 | 0.880 |
Why?
|
Polycyclic Aromatic Hydrocarbons | 8 | 2019 | 11 | 0.850 |
Why?
|
Asia | 18 | 2024 | 95 | 0.850 |
Why?
|
Occupational Exposure | 3 | 2010 | 80 | 0.840 |
Why?
|
Environmental Pollutants | 4 | 2018 | 51 | 0.830 |
Why?
|
Air Pollution | 4 | 2023 | 68 | 0.830 |
Why?
|
Air Pollutants | 4 | 2024 | 78 | 0.830 |
Why?
|
Skin Neoplasms | 7 | 2019 | 546 | 0.820 |
Why?
|
Respiration Disorders | 2 | 2013 | 39 | 0.820 |
Why?
|
Methylation | 8 | 2019 | 251 | 0.810 |
Why?
|
Air Pollution, Indoor | 4 | 2023 | 63 | 0.810 |
Why?
|
Vitamin E | 4 | 2014 | 35 | 0.800 |
Why?
|
Molecular Epidemiology | 5 | 2010 | 53 | 0.780 |
Why?
|
DNA Adducts | 9 | 2019 | 21 | 0.770 |
Why?
|
Mendelian Randomization Analysis | 5 | 2016 | 43 | 0.760 |
Why?
|
Selenomethionine | 2 | 2013 | 11 | 0.760 |
Why?
|
Manganese | 6 | 2019 | 53 | 0.760 |
Why?
|
Cause of Death | 10 | 2022 | 277 | 0.730 |
Why?
|
Sex Factors | 17 | 2021 | 1054 | 0.710 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2015 | 1197 | 0.710 |
Why?
|
Liver Neoplasms | 13 | 2012 | 736 | 0.700 |
Why?
|
Water Wells | 6 | 2022 | 18 | 0.700 |
Why?
|
Ammonia-Lyases | 1 | 2019 | 6 | 0.690 |
Why?
|
Glutamate Formimidoyltransferase | 1 | 2019 | 6 | 0.690 |
Why?
|
Parity | 4 | 2023 | 93 | 0.690 |
Why?
|
Polymorphism, Genetic | 6 | 2015 | 819 | 0.690 |
Why?
|
Telomere Homeostasis | 5 | 2021 | 30 | 0.690 |
Why?
|
Phenotype | 8 | 2019 | 2378 | 0.690 |
Why?
|
Carcinoma, Hepatocellular | 12 | 2012 | 384 | 0.670 |
Why?
|
Alleles | 11 | 2020 | 1128 | 0.660 |
Why?
|
Steroid 17-alpha-Hydroxylase | 3 | 2008 | 18 | 0.650 |
Why?
|
Aromatase | 3 | 2007 | 12 | 0.640 |
Why?
|
Research Design | 5 | 2018 | 594 | 0.640 |
Why?
|
Estrogens | 3 | 2008 | 200 | 0.620 |
Why?
|
Atherosclerosis | 6 | 2018 | 244 | 0.620 |
Why?
|
Gene Expression Profiling | 5 | 2014 | 1384 | 0.610 |
Why?
|
Hypertension | 7 | 2022 | 1141 | 0.610 |
Why?
|
Aging | 4 | 2020 | 691 | 0.610 |
Why?
|
Cacodylic Acid | 8 | 2021 | 22 | 0.610 |
Why?
|
Tertiary Prevention | 1 | 2017 | 2 | 0.610 |
Why?
|
Gene Expression Regulation | 6 | 2021 | 1920 | 0.610 |
Why?
|
Biomarkers | 14 | 2023 | 1718 | 0.590 |
Why?
|
Disease | 2 | 2010 | 90 | 0.580 |
Why?
|
Placental Lactogen | 2 | 2008 | 12 | 0.570 |
Why?
|
Carotid Artery Diseases | 4 | 2018 | 97 | 0.570 |
Why?
|
Chorionic Gonadotropin | 2 | 2008 | 72 | 0.560 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 171 | 0.560 |
Why?
|
Leukocytes | 6 | 2018 | 202 | 0.560 |
Why?
|
Malnutrition | 2 | 2021 | 34 | 0.560 |
Why?
|
Overweight | 4 | 2023 | 118 | 0.560 |
Why?
|
Surveys and Questionnaires | 15 | 2022 | 2501 | 0.540 |
Why?
|
Carcinoma, Basal Cell | 2 | 2015 | 54 | 0.530 |
Why?
|
Epigenesis, Genetic | 4 | 2019 | 479 | 0.530 |
Why?
|
Telomere Shortening | 4 | 2021 | 23 | 0.530 |
Why?
|
Survival Analysis | 4 | 2017 | 1538 | 0.520 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2015 | 1961 | 0.520 |
Why?
|
Thyroid Neoplasms | 4 | 2023 | 408 | 0.510 |
Why?
|
Social Class | 3 | 2017 | 128 | 0.500 |
Why?
|
Placenta | 2 | 2008 | 175 | 0.500 |
Why?
|
Specimen Handling | 4 | 2019 | 98 | 0.500 |
Why?
|
Arm | 2 | 2014 | 91 | 0.500 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 329 | 0.500 |
Why?
|
Accidents, Occupational | 1 | 2014 | 8 | 0.500 |
Why?
|
Feces | 4 | 2020 | 319 | 0.490 |
Why?
|
Human Rights Abuses | 1 | 2014 | 2 | 0.490 |
Why?
|
Industry | 1 | 2014 | 16 | 0.490 |
Why?
|
Water Quality | 1 | 2014 | 2 | 0.490 |
Why?
|
Phosphofructokinase-1, Muscle Type | 1 | 2014 | 9 | 0.490 |
Why?
|
Acids | 1 | 2014 | 13 | 0.490 |
Why?
|
Bias | 4 | 2011 | 127 | 0.480 |
Why?
|
Rural Health | 1 | 2014 | 20 | 0.480 |
Why?
|
Occupational Health | 1 | 2014 | 32 | 0.480 |
Why?
|
Chromosomes, Human, Pair 10 | 2 | 2023 | 47 | 0.480 |
Why?
|
Safety Management | 1 | 2014 | 56 | 0.480 |
Why?
|
Women | 1 | 2014 | 25 | 0.470 |
Why?
|
Hematuria | 1 | 2014 | 49 | 0.470 |
Why?
|
Population Surveillance | 3 | 2011 | 219 | 0.470 |
Why?
|
Tremor | 2 | 2011 | 22 | 0.470 |
Why?
|
Lung Neoplasms | 5 | 2024 | 2262 | 0.460 |
Why?
|
Digestive System Neoplasms | 1 | 2013 | 20 | 0.460 |
Why?
|
alpha-Tocopherol | 1 | 2013 | 9 | 0.460 |
Why?
|
DNA, Neoplasm | 3 | 2011 | 265 | 0.460 |
Why?
|
Keratoderma, Palmoplantar | 1 | 2013 | 3 | 0.460 |
Why?
|
Risk Assessment | 16 | 2023 | 2261 | 0.460 |
Why?
|
Feeding Behavior | 2 | 2015 | 324 | 0.450 |
Why?
|
Gastrointestinal Microbiome | 4 | 2020 | 455 | 0.450 |
Why?
|
Diet Records | 2 | 2012 | 19 | 0.450 |
Why?
|
Bacteria | 5 | 2020 | 447 | 0.450 |
Why?
|
Leukocytes, Mononuclear | 4 | 2022 | 196 | 0.450 |
Why?
|
Aflatoxin B1 | 7 | 2009 | 8 | 0.450 |
Why?
|
Anticarcinogenic Agents | 1 | 2013 | 70 | 0.440 |
Why?
|
Areca | 5 | 2014 | 9 | 0.440 |
Why?
|
Population Health | 2 | 2022 | 33 | 0.430 |
Why?
|
DNA Helicases | 3 | 2017 | 79 | 0.430 |
Why?
|
Age Factors | 10 | 2021 | 1851 | 0.420 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 296 | 0.420 |
Why?
|
Chromosome Aberrations | 3 | 2019 | 387 | 0.420 |
Why?
|
Violence | 1 | 2014 | 143 | 0.410 |
Why?
|
Tissue Fixation | 2 | 2012 | 40 | 0.410 |
Why?
|
Paraffin Embedding | 2 | 2012 | 78 | 0.410 |
Why?
|
Formaldehyde | 2 | 2012 | 52 | 0.410 |
Why?
|
Meat | 2 | 2013 | 26 | 0.410 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2015 | 1076 | 0.410 |
Why?
|
Risk | 9 | 2015 | 674 | 0.400 |
Why?
|
Arrhythmias, Cardiac | 1 | 2013 | 187 | 0.400 |
Why?
|
Genetic Loci | 4 | 2017 | 250 | 0.400 |
Why?
|
Follow-Up Studies | 8 | 2018 | 3640 | 0.400 |
Why?
|
Methionine | 2 | 2008 | 66 | 0.400 |
Why?
|
Essential Tremor | 1 | 2011 | 6 | 0.390 |
Why?
|
Seafood | 4 | 2015 | 10 | 0.390 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2011 | 80 | 0.390 |
Why?
|
Carcinoma | 2 | 2015 | 436 | 0.390 |
Why?
|
Promoter Regions, Genetic | 4 | 2008 | 937 | 0.390 |
Why?
|
Sunlight | 2 | 2010 | 26 | 0.380 |
Why?
|
Cysteine | 2 | 2008 | 135 | 0.380 |
Why?
|
Lung | 3 | 2023 | 1170 | 0.370 |
Why?
|
Chicago | 7 | 2024 | 1379 | 0.370 |
Why?
|
Obesity | 9 | 2023 | 963 | 0.370 |
Why?
|
Gene Frequency | 4 | 2019 | 677 | 0.370 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 3 | 2015 | 56 | 0.370 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 2015 | 71 | 0.370 |
Why?
|
Carotid Arteries | 2 | 2013 | 127 | 0.370 |
Why?
|
Loss of Heterozygosity | 3 | 2012 | 85 | 0.370 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2017 | 153 | 0.370 |
Why?
|
Pregnancy | 12 | 2024 | 2894 | 0.360 |
Why?
|
Regression Analysis | 7 | 2017 | 596 | 0.360 |
Why?
|
Patient Compliance | 1 | 2011 | 227 | 0.360 |
Why?
|
Tobacco Smoking | 2 | 2020 | 25 | 0.360 |
Why?
|
CpG Islands | 9 | 2019 | 151 | 0.350 |
Why?
|
Health Surveys | 2 | 2011 | 239 | 0.350 |
Why?
|
Amino Acids | 1 | 2010 | 252 | 0.350 |
Why?
|
Logistic Models | 9 | 2024 | 1186 | 0.340 |
Why?
|
Prostatic Neoplasms | 5 | 2016 | 1721 | 0.340 |
Why?
|
DNA | 6 | 2023 | 1294 | 0.340 |
Why?
|
Causality | 3 | 2013 | 81 | 0.330 |
Why?
|
Microbiota | 3 | 2018 | 381 | 0.330 |
Why?
|
Carcinoma, Papillary | 2 | 2023 | 158 | 0.330 |
Why?
|
Reproducibility of Results | 10 | 2019 | 2705 | 0.330 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 865 | 0.330 |
Why?
|
Poverty | 3 | 2018 | 173 | 0.330 |
Why?
|
Mutation | 7 | 2023 | 3968 | 0.330 |
Why?
|
Transcriptome | 5 | 2024 | 580 | 0.320 |
Why?
|
RNA, Ribosomal, 16S | 5 | 2020 | 241 | 0.320 |
Why?
|
Protein Carbonylation | 1 | 2008 | 10 | 0.320 |
Why?
|
Anthropometry | 3 | 2019 | 74 | 0.310 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 2 | 2006 | 44 | 0.310 |
Why?
|
Gene Amplification | 1 | 2008 | 131 | 0.310 |
Why?
|
Socioeconomic Factors | 5 | 2017 | 567 | 0.310 |
Why?
|
Life Style | 5 | 2024 | 189 | 0.310 |
Why?
|
Receptors, Estrogen | 5 | 2017 | 384 | 0.310 |
Why?
|
Postmenopause | 1 | 2008 | 98 | 0.310 |
Why?
|
Infant Mortality | 1 | 2007 | 59 | 0.300 |
Why?
|
Catechol O-Methyltransferase | 2 | 2006 | 68 | 0.300 |
Why?
|
Inflammation | 4 | 2024 | 920 | 0.300 |
Why?
|
Multifactorial Inheritance | 5 | 2024 | 159 | 0.300 |
Why?
|
Urinary Bladder Neoplasms | 3 | 2015 | 383 | 0.290 |
Why?
|
Anemia | 1 | 2008 | 128 | 0.290 |
Why?
|
Age of Onset | 4 | 2018 | 310 | 0.290 |
Why?
|
Gene Expression | 2 | 2018 | 1284 | 0.280 |
Why?
|
Homocysteine | 5 | 2018 | 29 | 0.280 |
Why?
|
Public Health | 4 | 2013 | 129 | 0.280 |
Why?
|
Drinking | 3 | 2011 | 34 | 0.280 |
Why?
|
Tunica Intima | 1 | 2006 | 59 | 0.280 |
Why?
|
Models, Genetic | 3 | 2018 | 926 | 0.280 |
Why?
|
Interleukin-17 | 2 | 2024 | 101 | 0.280 |
Why?
|
Smoke | 3 | 2019 | 27 | 0.280 |
Why?
|
Vegetables | 3 | 2017 | 45 | 0.280 |
Why?
|
Chronic Disease | 3 | 2020 | 971 | 0.270 |
Why?
|
Spectrophotometry, Atomic | 4 | 2013 | 12 | 0.270 |
Why?
|
Aged, 80 and over | 10 | 2016 | 6509 | 0.270 |
Why?
|
Mass Spectrometry | 4 | 2013 | 188 | 0.270 |
Why?
|
Mass Screening | 4 | 2017 | 618 | 0.270 |
Why?
|
Diabetes Mellitus | 5 | 2016 | 806 | 0.260 |
Why?
|
Lymphocytes | 2 | 2009 | 464 | 0.260 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2015 | 51 | 0.260 |
Why?
|
Child | 12 | 2022 | 6927 | 0.250 |
Why?
|
Developing Countries | 3 | 2015 | 71 | 0.250 |
Why?
|
Educational Status | 3 | 2022 | 188 | 0.250 |
Why?
|
Alcohol Drinking | 2 | 2019 | 267 | 0.250 |
Why?
|
Intelligence | 3 | 2011 | 71 | 0.250 |
Why?
|
Microsatellite Repeats | 2 | 2024 | 145 | 0.250 |
Why?
|
Hepatitis B | 4 | 2009 | 74 | 0.250 |
Why?
|
Vitamin B 12 | 4 | 2009 | 24 | 0.250 |
Why?
|
Epidemiologic Studies | 3 | 2010 | 17 | 0.240 |
Why?
|
Smoking Cessation | 2 | 2019 | 230 | 0.240 |
Why?
|
Cholelithiasis | 1 | 2023 | 34 | 0.240 |
Why?
|
Prognosis | 5 | 2018 | 3679 | 0.240 |
Why?
|
Biliary Tract Neoplasms | 1 | 2023 | 33 | 0.240 |
Why?
|
Adenocarcinoma | 1 | 2011 | 1169 | 0.230 |
Why?
|
Petroleum | 1 | 2023 | 13 | 0.230 |
Why?
|
Radius Fractures | 1 | 2003 | 30 | 0.230 |
Why?
|
Proteins | 3 | 2010 | 777 | 0.230 |
Why?
|
Demography | 2 | 2015 | 177 | 0.230 |
Why?
|
Sex Distribution | 3 | 2013 | 173 | 0.220 |
Why?
|
Functional Laterality | 1 | 2003 | 201 | 0.220 |
Why?
|
Insurance Coverage | 1 | 2023 | 117 | 0.220 |
Why?
|
Metabolome | 1 | 2023 | 47 | 0.220 |
Why?
|
Confidence Intervals | 4 | 2013 | 229 | 0.220 |
Why?
|
Double-Blind Method | 5 | 2013 | 1823 | 0.220 |
Why?
|
Residence Characteristics | 2 | 2022 | 197 | 0.210 |
Why?
|
Particulate Matter | 4 | 2023 | 79 | 0.210 |
Why?
|
Maternal Exposure | 3 | 2017 | 57 | 0.210 |
Why?
|
Fathers | 1 | 2003 | 70 | 0.210 |
Why?
|
Intestinal Neoplasms | 1 | 2022 | 56 | 0.210 |
Why?
|
DNA, Bacterial | 2 | 2019 | 236 | 0.210 |
Why?
|
Health Status | 2 | 2015 | 360 | 0.210 |
Why?
|
Respiratory Tract Diseases | 2 | 2014 | 45 | 0.210 |
Why?
|
Oxidative Stress | 2 | 2006 | 447 | 0.200 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2022 | 57 | 0.200 |
Why?
|
Vitamin D | 2 | 2022 | 261 | 0.200 |
Why?
|
Early Detection of Cancer | 2 | 2023 | 394 | 0.200 |
Why?
|
Linear Models | 6 | 2018 | 421 | 0.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2006 | 508 | 0.200 |
Why?
|
Age Distribution | 4 | 2011 | 204 | 0.200 |
Why?
|
Blood Proteins | 1 | 2021 | 144 | 0.200 |
Why?
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2021 | 41 | 0.200 |
Why?
|
Gene Dosage | 3 | 2012 | 207 | 0.200 |
Why?
|
Gravidity | 1 | 2020 | 7 | 0.190 |
Why?
|
Endometrial Neoplasms | 1 | 2023 | 193 | 0.190 |
Why?
|
China | 4 | 2024 | 228 | 0.190 |
Why?
|
Transcription Factors | 3 | 2017 | 1565 | 0.190 |
Why?
|
Taiwan | 7 | 2013 | 23 | 0.190 |
Why?
|
Epigenomics | 2 | 2024 | 100 | 0.190 |
Why?
|
DNA-Binding Proteins | 2 | 2003 | 1208 | 0.190 |
Why?
|
Chemically-Induced Disorders | 1 | 2020 | 2 | 0.190 |
Why?
|
Poverty Areas | 1 | 2020 | 37 | 0.180 |
Why?
|
Information Seeking Behavior | 1 | 2020 | 12 | 0.180 |
Why?
|
Leiomyoma | 1 | 2024 | 191 | 0.180 |
Why?
|
Medicare | 1 | 2023 | 410 | 0.180 |
Why?
|
Uterine Neoplasms | 1 | 2024 | 227 | 0.180 |
Why?
|
HLA-DR Antigens | 1 | 2019 | 61 | 0.180 |
Why?
|
Epidemiologic Methods | 2 | 2010 | 59 | 0.180 |
Why?
|
Esophageal Neoplasms | 1 | 2022 | 321 | 0.180 |
Why?
|
Fruit | 2 | 2017 | 75 | 0.180 |
Why?
|
Blood | 1 | 2019 | 69 | 0.180 |
Why?
|
Stomach Neoplasms | 1 | 2022 | 266 | 0.180 |
Why?
|
Skin | 2 | 2014 | 554 | 0.180 |
Why?
|
Health Education | 3 | 2019 | 101 | 0.180 |
Why?
|
Multifunctional Enzymes | 1 | 2019 | 6 | 0.170 |
Why?
|
Data Interpretation, Statistical | 2 | 2011 | 297 | 0.170 |
Why?
|
Autophagy | 1 | 2021 | 149 | 0.170 |
Why?
|
Research Subjects | 1 | 2020 | 73 | 0.170 |
Why?
|
Cigarette Smoking | 1 | 2019 | 30 | 0.170 |
Why?
|
Disease Progression | 1 | 2024 | 1531 | 0.170 |
Why?
|
Organ Specificity | 3 | 2020 | 258 | 0.170 |
Why?
|
Carcinogenesis | 1 | 2021 | 195 | 0.170 |
Why?
|
Data Collection | 3 | 2022 | 372 | 0.170 |
Why?
|
Diet Surveys | 3 | 2015 | 20 | 0.170 |
Why?
|
Fertilizers | 2 | 2010 | 8 | 0.170 |
Why?
|
BRCA1 Protein | 2 | 2017 | 200 | 0.170 |
Why?
|
Receptors, Opioid | 1 | 2019 | 24 | 0.170 |
Why?
|
Receptors, Adiponectin | 2 | 2008 | 4 | 0.170 |
Why?
|
MicroRNAs | 2 | 2015 | 534 | 0.170 |
Why?
|
Administration, Oral | 2 | 2014 | 684 | 0.170 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2018 | 40 | 0.170 |
Why?
|
Glutathione Transferase | 4 | 2007 | 111 | 0.170 |
Why?
|
Pesticides | 2 | 2010 | 29 | 0.170 |
Why?
|
Adiponectin | 2 | 2008 | 24 | 0.160 |
Why?
|
Computer Simulation | 4 | 2018 | 1078 | 0.160 |
Why?
|
Dietary Supplements | 3 | 2008 | 128 | 0.160 |
Why?
|
Adenosine | 1 | 2021 | 225 | 0.160 |
Why?
|
Asthma | 2 | 2023 | 955 | 0.160 |
Why?
|
Monocytes | 1 | 2019 | 214 | 0.160 |
Why?
|
Comorbidity | 2 | 2013 | 943 | 0.160 |
Why?
|
Principal Component Analysis | 2 | 2010 | 155 | 0.160 |
Why?
|
Biomedical Research | 1 | 2022 | 376 | 0.160 |
Why?
|
Immunity | 1 | 2019 | 136 | 0.160 |
Why?
|
Severity of Illness Index | 4 | 2013 | 1801 | 0.160 |
Why?
|
Body Height | 2 | 2015 | 99 | 0.160 |
Why?
|
Cooking | 3 | 2023 | 55 | 0.160 |
Why?
|
Child Mortality | 1 | 2017 | 5 | 0.160 |
Why?
|
Saliva | 1 | 2018 | 122 | 0.160 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 55 | 0.150 |
Why?
|
Mutation, Missense | 1 | 2019 | 276 | 0.150 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 241 | 0.150 |
Why?
|
Naltrexone | 1 | 2019 | 135 | 0.150 |
Why?
|
Folic Acid Deficiency | 2 | 2008 | 7 | 0.150 |
Why?
|
Dietary Exposure | 1 | 2017 | 2 | 0.150 |
Why?
|
Cluster Analysis | 3 | 2018 | 369 | 0.150 |
Why?
|
Haplotypes | 3 | 2008 | 642 | 0.150 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 272 | 0.150 |
Why?
|
Hyperhomocysteinemia | 2 | 2008 | 11 | 0.150 |
Why?
|
Chromosomes, Human | 1 | 2017 | 66 | 0.150 |
Why?
|
Narcotic Antagonists | 1 | 2019 | 154 | 0.150 |
Why?
|
Sleep | 1 | 2021 | 444 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2021 | 427 | 0.150 |
Why?
|
Activin Receptors, Type I | 3 | 2005 | 12 | 0.150 |
Why?
|
Diet, Gluten-Free | 1 | 2017 | 52 | 0.150 |
Why?
|
T-Lymphocytes | 2 | 2020 | 1195 | 0.150 |
Why?
|
Periodontal Diseases | 1 | 2016 | 9 | 0.150 |
Why?
|
New York | 3 | 2015 | 69 | 0.150 |
Why?
|
Global Burden of Disease | 1 | 2016 | 10 | 0.150 |
Why?
|
Receptors, Progesterone | 2 | 2016 | 167 | 0.140 |
Why?
|
Receptors, Transforming Growth Factor beta | 3 | 2005 | 40 | 0.140 |
Why?
|
Macrophages | 1 | 2019 | 554 | 0.140 |
Why?
|
Republic of Korea | 3 | 2024 | 31 | 0.140 |
Why?
|
Selenium Compounds | 1 | 2016 | 3 | 0.140 |
Why?
|
Patient Selection | 1 | 2020 | 685 | 0.140 |
Why?
|
Immunity, Innate | 1 | 2019 | 409 | 0.140 |
Why?
|
Anions | 1 | 2016 | 31 | 0.140 |
Why?
|
Child, Preschool | 5 | 2021 | 3612 | 0.140 |
Why?
|
Quality of Life | 2 | 2015 | 1585 | 0.140 |
Why?
|
Bile | 1 | 2016 | 57 | 0.140 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2016 | 135 | 0.140 |
Why?
|
Parents | 1 | 2018 | 272 | 0.140 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2015 | 9 | 0.140 |
Why?
|
Pregnancy Outcome | 1 | 2017 | 247 | 0.140 |
Why?
|
Cytochrome P-450 CYP1B1 | 2 | 2006 | 9 | 0.140 |
Why?
|
Japan | 3 | 2024 | 307 | 0.130 |
Why?
|
Mammals | 1 | 2017 | 227 | 0.130 |
Why?
|
Multiple Myeloma | 1 | 2019 | 307 | 0.130 |
Why?
|
Computational Biology | 1 | 2018 | 528 | 0.130 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2015 | 28 | 0.130 |
Why?
|
Metabolic Syndrome | 1 | 2016 | 141 | 0.130 |
Why?
|
Down-Regulation | 2 | 2021 | 504 | 0.130 |
Why?
|
Intelligence Tests | 4 | 2011 | 38 | 0.130 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 1075 | 0.130 |
Why?
|
Blotting, Southern | 1 | 2014 | 129 | 0.130 |
Why?
|
Spirituality | 1 | 2015 | 87 | 0.130 |
Why?
|
Heterozygote | 3 | 2017 | 365 | 0.130 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 51 | 0.130 |
Why?
|
B-Lymphocytes | 1 | 2019 | 724 | 0.130 |
Why?
|
Epistasis, Genetic | 2 | 2018 | 86 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 70 | 0.130 |
Why?
|
Interviews as Topic | 4 | 2011 | 319 | 0.120 |
Why?
|
Pilot Projects | 2 | 2008 | 839 | 0.120 |
Why?
|
Chemoprevention | 1 | 2014 | 91 | 0.120 |
Why?
|
Creatinine | 4 | 2008 | 338 | 0.120 |
Why?
|
Drug Therapy, Combination | 2 | 2008 | 894 | 0.120 |
Why?
|
Reagent Strips | 1 | 2014 | 6 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2006 | 104 | 0.120 |
Why?
|
Survivors | 1 | 2015 | 226 | 0.120 |
Why?
|
Up-Regulation | 2 | 2021 | 712 | 0.120 |
Why?
|
Genetic Testing | 2 | 2010 | 535 | 0.120 |
Why?
|
Models, Statistical | 3 | 2016 | 574 | 0.120 |
Why?
|
Food Analysis | 2 | 2011 | 4 | 0.120 |
Why?
|
Community Health Planning | 2 | 2011 | 21 | 0.120 |
Why?
|
Global Health | 1 | 2015 | 193 | 0.120 |
Why?
|
Sex Characteristics | 2 | 2019 | 319 | 0.120 |
Why?
|
Chromosomes, Human, Pair 2 | 2 | 2016 | 85 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 860 | 0.120 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 136 | 0.120 |
Why?
|
Animals | 12 | 2021 | 26582 | 0.120 |
Why?
|
Organ Size | 1 | 2014 | 364 | 0.110 |
Why?
|
Tongue Diseases | 1 | 2013 | 8 | 0.110 |
Why?
|
Polymerase Chain Reaction | 3 | 2004 | 927 | 0.110 |
Why?
|
Genetic Markers | 3 | 2020 | 476 | 0.110 |
Why?
|
Stomatitis | 1 | 2013 | 30 | 0.110 |
Why?
|
Multivariate Analysis | 3 | 2015 | 999 | 0.110 |
Why?
|
Databases, Genetic | 2 | 2012 | 260 | 0.110 |
Why?
|
Epidemiological Monitoring | 2 | 2010 | 39 | 0.110 |
Why?
|
Urinary Bladder | 1 | 2015 | 246 | 0.110 |
Why?
|
Social Behavior | 1 | 2015 | 294 | 0.110 |
Why?
|
Chi-Square Distribution | 3 | 2011 | 364 | 0.110 |
Why?
|
Fishes | 2 | 2013 | 137 | 0.110 |
Why?
|
Chromosome Mapping | 2 | 2022 | 1074 | 0.110 |
Why?
|
Genomics | 1 | 2018 | 720 | 0.110 |
Why?
|
Pedigree | 2 | 2004 | 966 | 0.110 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2013 | 315 | 0.110 |
Why?
|
United States | 6 | 2023 | 6672 | 0.100 |
Why?
|
Motor Skills Disorders | 1 | 2011 | 15 | 0.100 |
Why?
|
Manganese Poisoning | 1 | 2011 | 1 | 0.100 |
Why?
|
Unfolded Protein Response | 1 | 2011 | 39 | 0.100 |
Why?
|
Survival Rate | 2 | 2016 | 1863 | 0.100 |
Why?
|
Child Development | 2 | 2011 | 163 | 0.100 |
Why?
|
Analysis of Variance | 2 | 2010 | 912 | 0.100 |
Why?
|
Mental Health | 1 | 2012 | 162 | 0.100 |
Why?
|
Cucurbitaceae | 1 | 2010 | 4 | 0.100 |
Why?
|
Urinalysis | 1 | 2011 | 33 | 0.100 |
Why?
|
Motor Skills | 1 | 2011 | 71 | 0.100 |
Why?
|
Genes, Neoplasm | 1 | 2010 | 37 | 0.100 |
Why?
|
Body Weight | 3 | 2019 | 459 | 0.100 |
Why?
|
Child Behavior | 1 | 2011 | 48 | 0.100 |
Why?
|
India | 1 | 2011 | 120 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2011 | 222 | 0.090 |
Why?
|
Electrocardiography | 1 | 2013 | 478 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 307 | 0.090 |
Why?
|
Metabolomics | 2 | 2023 | 68 | 0.090 |
Why?
|
Stroke | 3 | 2015 | 965 | 0.090 |
Why?
|
Seeds | 1 | 2010 | 49 | 0.090 |
Why?
|
Protective Agents | 1 | 2010 | 33 | 0.090 |
Why?
|
Therapeutics | 1 | 2010 | 12 | 0.090 |
Why?
|
Energy Intake | 1 | 2010 | 98 | 0.090 |
Why?
|
Algorithms | 2 | 2022 | 1830 | 0.090 |
Why?
|
Water | 1 | 2011 | 277 | 0.090 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 744 | 0.090 |
Why?
|
Peroxidase | 2 | 2012 | 51 | 0.090 |
Why?
|
Real-Time Polymerase Chain Reaction | 3 | 2016 | 273 | 0.090 |
Why?
|
Mutagens | 1 | 2009 | 31 | 0.090 |
Why?
|
Oximetry | 1 | 2009 | 84 | 0.090 |
Why?
|
Gamma Rays | 1 | 2009 | 72 | 0.080 |
Why?
|
Electronic Health Records | 2 | 2022 | 319 | 0.080 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2008 | 36 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2023 | 683 | 0.080 |
Why?
|
Vitamin A | 1 | 2008 | 27 | 0.080 |
Why?
|
Ascorbic Acid | 1 | 2008 | 37 | 0.080 |
Why?
|
Colon | 1 | 2012 | 496 | 0.080 |
Why?
|
Healthy Volunteers | 2 | 2019 | 143 | 0.080 |
Why?
|
Dinoprost | 1 | 2008 | 26 | 0.080 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2008 | 42 | 0.080 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2008 | 79 | 0.080 |
Why?
|
Physicians, Family | 1 | 2008 | 40 | 0.080 |
Why?
|
DNA, Mitochondrial | 1 | 2009 | 183 | 0.080 |
Why?
|
Estrogen Replacement Therapy | 1 | 2008 | 45 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2008 | 100 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2009 | 151 | 0.080 |
Why?
|
Ultraviolet Rays | 1 | 2009 | 193 | 0.080 |
Why?
|
Premenopause | 1 | 2007 | 54 | 0.080 |
Why?
|
Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2007 | 4 | 0.080 |
Why?
|
Precision Medicine | 1 | 2012 | 395 | 0.080 |
Why?
|
Feasibility Studies | 3 | 2019 | 751 | 0.080 |
Why?
|
Choline | 1 | 2007 | 23 | 0.080 |
Why?
|
Linkage Disequilibrium | 2 | 2008 | 473 | 0.080 |
Why?
|
Gene Silencing | 2 | 2005 | 172 | 0.080 |
Why?
|
Hemoglobins | 1 | 2008 | 179 | 0.080 |
Why?
|
Carcinogens | 2 | 2009 | 108 | 0.080 |
Why?
|
Breast Feeding | 1 | 2008 | 91 | 0.080 |
Why?
|
X-Ray Absorption Spectroscopy | 2 | 2017 | 3 | 0.080 |
Why?
|
Niacin | 1 | 2007 | 37 | 0.080 |
Why?
|
Deoxyadenine Nucleotides | 1 | 2006 | 1 | 0.070 |
Why?
|
Waist-Hip Ratio | 2 | 2019 | 18 | 0.070 |
Why?
|
Waist Circumference | 2 | 2019 | 20 | 0.070 |
Why?
|
Ownership | 1 | 2007 | 26 | 0.070 |
Why?
|
Isoenzymes | 2 | 2005 | 271 | 0.070 |
Why?
|
Oxidation-Reduction | 1 | 2008 | 373 | 0.070 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 2 | 2003 | 4 | 0.070 |
Why?
|
Hepatitis B, Chronic | 1 | 2007 | 32 | 0.070 |
Why?
|
Hydroxyestrones | 1 | 2006 | 4 | 0.070 |
Why?
|
Genes, p53 | 2 | 2006 | 109 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2019 | 7993 | 0.070 |
Why?
|
Infant | 2 | 2017 | 3046 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2006 | 381 | 0.070 |
Why?
|
Population Groups | 1 | 2006 | 41 | 0.070 |
Why?
|
Organometallic Compounds | 1 | 2007 | 132 | 0.070 |
Why?
|
RNA, Messenger | 3 | 2021 | 1981 | 0.070 |
Why?
|
Codon | 1 | 2006 | 124 | 0.070 |
Why?
|
Melanosis | 1 | 2005 | 3 | 0.070 |
Why?
|
Pharmacogenetics | 1 | 2010 | 434 | 0.070 |
Why?
|
Infant, Newborn | 3 | 2017 | 2379 | 0.070 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2005 | 7 | 0.070 |
Why?
|
Carcinogens, Environmental | 1 | 2005 | 5 | 0.070 |
Why?
|
Benchmarking | 1 | 2005 | 78 | 0.070 |
Why?
|
New York City | 4 | 2008 | 59 | 0.070 |
Why?
|
Estradiol | 1 | 2006 | 252 | 0.070 |
Why?
|
Nuclear Family | 1 | 2005 | 92 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2007 | 1673 | 0.060 |
Why?
|
Environmental Pollution | 1 | 2004 | 13 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 2 | 2007 | 279 | 0.060 |
Why?
|
Registries | 2 | 2008 | 702 | 0.060 |
Why?
|
Base Sequence | 3 | 2021 | 2330 | 0.060 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2005 | 85 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2010 | 567 | 0.060 |
Why?
|
Enteroendocrine Cells | 1 | 2024 | 6 | 0.060 |
Why?
|
Lead | 3 | 2011 | 26 | 0.060 |
Why?
|
Genetic Privacy | 1 | 2023 | 12 | 0.060 |
Why?
|
Resistin | 1 | 2023 | 14 | 0.060 |
Why?
|
Catalase | 1 | 2003 | 48 | 0.060 |
Why?
|
Soot | 1 | 2023 | 2 | 0.060 |
Why?
|
Reproductive History | 1 | 2023 | 8 | 0.060 |
Why?
|
Ghrelin | 1 | 2023 | 29 | 0.060 |
Why?
|
Troponin | 1 | 2023 | 24 | 0.060 |
Why?
|
Chromosomes, Human, Y | 1 | 2023 | 22 | 0.060 |
Why?
|
Transportation | 1 | 2003 | 18 | 0.060 |
Why?
|
Ultrasonography | 1 | 2006 | 695 | 0.060 |
Why?
|
Smokers | 1 | 2023 | 41 | 0.060 |
Why?
|
Aminobiphenyl Compounds | 1 | 2003 | 1 | 0.060 |
Why?
|
Medically Uninsured | 1 | 2023 | 58 | 0.060 |
Why?
|
Hormones | 1 | 2024 | 141 | 0.060 |
Why?
|
C-Peptide | 1 | 2023 | 174 | 0.060 |
Why?
|
Leptin | 1 | 2023 | 105 | 0.060 |
Why?
|
Genomic Instability | 1 | 2023 | 79 | 0.060 |
Why?
|
Carbon Monoxide | 1 | 2023 | 90 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 301 | 0.060 |
Why?
|
Trauma Centers | 1 | 2003 | 116 | 0.060 |
Why?
|
Peripheral Arterial Disease | 1 | 2024 | 88 | 0.060 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2003 | 118 | 0.060 |
Why?
|
RNA | 1 | 2007 | 560 | 0.050 |
Why?
|
Adipocytes | 1 | 2024 | 155 | 0.050 |
Why?
|
Practice Patterns, Physicians' | 1 | 2008 | 582 | 0.050 |
Why?
|
Mice | 4 | 2021 | 11352 | 0.050 |
Why?
|
Coffee | 1 | 2022 | 10 | 0.050 |
Why?
|
Insurance, Health | 1 | 2023 | 160 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2004 | 236 | 0.050 |
Why?
|
Panic Disorder | 1 | 2002 | 22 | 0.050 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 134 | 0.050 |
Why?
|
Tea | 1 | 2022 | 19 | 0.050 |
Why?
|
Marital Status | 1 | 2022 | 40 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2023 | 256 | 0.050 |
Why?
|
Ambulatory Care | 1 | 2023 | 181 | 0.050 |
Why?
|
Mastication | 2 | 2014 | 76 | 0.050 |
Why?
|
Research | 1 | 2003 | 253 | 0.050 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 138 | 0.050 |
Why?
|
Singapore | 1 | 2021 | 16 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2020 | 1578 | 0.050 |
Why?
|
Vitamins | 1 | 2022 | 81 | 0.050 |
Why?
|
Blotting, Western | 2 | 2015 | 782 | 0.050 |
Why?
|
Th17 Cells | 1 | 2022 | 80 | 0.050 |
Why?
|
Islam | 1 | 2022 | 34 | 0.050 |
Why?
|
Nedd4 Ubiquitin Protein Ligases | 1 | 2021 | 14 | 0.050 |
Why?
|
Immunity, Humoral | 1 | 2022 | 67 | 0.050 |
Why?
|
Gene Ontology | 1 | 2021 | 34 | 0.050 |
Why?
|
Biomass | 1 | 2021 | 32 | 0.050 |
Why?
|
Sequestosome-1 Protein | 1 | 2021 | 22 | 0.050 |
Why?
|
Diabetic Nephropathies | 1 | 2024 | 248 | 0.050 |
Why?
|
Vacuoles | 1 | 2021 | 46 | 0.050 |
Why?
|
Chromatin | 1 | 2024 | 380 | 0.050 |
Why?
|
Liver | 2 | 2006 | 1230 | 0.050 |
Why?
|
Protein Stability | 1 | 2021 | 99 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2024 | 428 | 0.050 |
Why?
|
Medicaid | 1 | 2023 | 217 | 0.050 |
Why?
|
Epidermis | 1 | 2021 | 100 | 0.050 |
Why?
|
RNA Stability | 1 | 2021 | 86 | 0.050 |
Why?
|
Lysosomes | 1 | 2021 | 104 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2004 | 484 | 0.050 |
Why?
|
Islets of Langerhans | 1 | 2024 | 544 | 0.050 |
Why?
|
Diabetes Complications | 1 | 2002 | 207 | 0.050 |
Why?
|
Keratinocytes | 1 | 2021 | 143 | 0.050 |
Why?
|
Immunochemistry | 1 | 2019 | 16 | 0.050 |
Why?
|
Streptococcus pneumoniae | 1 | 2019 | 48 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2015 | 303 | 0.040 |
Why?
|
Antibodies, Bacterial | 1 | 2019 | 95 | 0.040 |
Why?
|
Clostridiales | 1 | 2019 | 17 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2022 | 238 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2024 | 350 | 0.040 |
Why?
|
Attitude | 1 | 2020 | 127 | 0.040 |
Why?
|
Metals, Heavy | 1 | 2019 | 15 | 0.040 |
Why?
|
HEK293 Cells | 1 | 2021 | 615 | 0.040 |
Why?
|
Cetylpyridinium | 1 | 2018 | 2 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2002 | 532 | 0.040 |
Why?
|
Primary Health Care | 1 | 2022 | 339 | 0.040 |
Why?
|
Parturition | 1 | 2018 | 21 | 0.040 |
Why?
|
Ions | 1 | 2019 | 74 | 0.040 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2018 | 11 | 0.040 |
Why?
|
Hospitalization | 1 | 2004 | 849 | 0.040 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2018 | 79 | 0.040 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2018 | 40 | 0.040 |
Why?
|
Drug Combinations | 1 | 2018 | 224 | 0.040 |
Why?
|
Penetrance | 1 | 2018 | 44 | 0.040 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2017 | 10 | 0.040 |
Why?
|
Synchrotrons | 1 | 2017 | 28 | 0.040 |
Why?
|
Mesocricetus | 1 | 2017 | 107 | 0.040 |
Why?
|
Abortion, Therapeutic | 1 | 2017 | 11 | 0.040 |
Why?
|
Stillbirth | 1 | 2017 | 9 | 0.040 |
Why?
|
Bayes Theorem | 1 | 2019 | 361 | 0.040 |
Why?
|
Rats | 2 | 2016 | 3990 | 0.040 |
Why?
|
NF-kappa B | 1 | 2021 | 444 | 0.040 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 135 | 0.040 |
Why?
|
Coronary Disease | 2 | 2013 | 261 | 0.040 |
Why?
|
Freezing | 1 | 2017 | 33 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2011 | 480 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2017 | 290 | 0.040 |
Why?
|
Retrospective Studies | 1 | 2011 | 8489 | 0.040 |
Why?
|
Longevity | 1 | 2017 | 51 | 0.040 |
Why?
|
Genes, p16 | 2 | 2007 | 11 | 0.040 |
Why?
|
Europe | 1 | 2017 | 309 | 0.040 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2017 | 148 | 0.040 |
Why?
|
Abortion, Spontaneous | 1 | 2017 | 66 | 0.040 |
Why?
|
Cyclophilins | 1 | 2016 | 8 | 0.040 |
Why?
|
tRNA Methyltransferases | 1 | 2016 | 12 | 0.040 |
Why?
|
Creatine | 2 | 2006 | 23 | 0.040 |
Why?
|
Time Factors | 2 | 2015 | 5210 | 0.040 |
Why?
|
Menopause | 1 | 2016 | 71 | 0.040 |
Why?
|
Drug Antagonism | 1 | 2016 | 7 | 0.040 |
Why?
|
Nutritional Status | 2 | 2007 | 83 | 0.030 |
Why?
|
DNA Damage | 2 | 2009 | 366 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2015 | 56 | 0.030 |
Why?
|
Inositol Polyphosphate 5-Phosphatases | 1 | 2015 | 2 | 0.030 |
Why?
|
Canada | 1 | 2015 | 204 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2016 | 297 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 1991 | 0.030 |
Why?
|
Molecular Structure | 1 | 2016 | 287 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2015 | 96 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 87 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 503 | 0.030 |
Why?
|
Binding Sites | 1 | 2017 | 1098 | 0.030 |
Why?
|
Rabbits | 1 | 2016 | 636 | 0.030 |
Why?
|
Biological Assay | 1 | 2014 | 78 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2015 | 204 | 0.030 |
Why?
|
Glutathione S-Transferase pi | 2 | 2005 | 18 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 128 | 0.030 |
Why?
|
Groundwater | 1 | 2014 | 10 | 0.030 |
Why?
|
Thigh | 1 | 2013 | 38 | 0.030 |
Why?
|
Poultry | 1 | 2013 | 22 | 0.030 |
Why?
|
Quality Control | 1 | 2014 | 117 | 0.030 |
Why?
|
Exercise | 1 | 2017 | 315 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2015 | 182 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2015 | 294 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2015 | 460 | 0.030 |
Why?
|
Cost of Illness | 1 | 2014 | 150 | 0.030 |
Why?
|
United States Environmental Protection Agency | 1 | 2013 | 5 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 552 | 0.030 |
Why?
|
Mouth Diseases | 1 | 2013 | 15 | 0.030 |
Why?
|
Cattle | 1 | 2013 | 376 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 429 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 879 | 0.030 |
Why?
|
Mouth Mucosa | 1 | 2013 | 67 | 0.030 |
Why?
|
E-Selectin | 1 | 2012 | 30 | 0.030 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2012 | 36 | 0.030 |
Why?
|
Genes, Homeobox | 1 | 2012 | 81 | 0.030 |
Why?
|
Tobacco, Smokeless | 1 | 2011 | 10 | 0.030 |
Why?
|
Latin America | 1 | 2011 | 14 | 0.030 |
Why?
|
Mice, Hairless | 1 | 2011 | 5 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2012 | 78 | 0.030 |
Why?
|
Activating Transcription Factor 6 | 1 | 2011 | 5 | 0.030 |
Why?
|
Frozen Sections | 1 | 2012 | 48 | 0.030 |
Why?
|
Transcription Factor CHOP | 1 | 2011 | 15 | 0.030 |
Why?
|
Mosaicism | 1 | 2012 | 67 | 0.030 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2012 | 85 | 0.030 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2012 | 110 | 0.030 |
Why?
|
Nails | 1 | 2011 | 7 | 0.030 |
Why?
|
eIF-2 Kinase | 1 | 2011 | 46 | 0.030 |
Why?
|
Verbal Behavior | 1 | 2011 | 32 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2012 | 229 | 0.020 |
Why?
|
Cell Movement | 1 | 2015 | 758 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 316 | 0.020 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2011 | 16 | 0.020 |
Why?
|
Comprehension | 1 | 2011 | 79 | 0.020 |
Why?
|
Geography | 1 | 2011 | 223 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2006 | 1753 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 179 | 0.020 |
Why?
|
Drug Interactions | 1 | 2011 | 248 | 0.020 |
Why?
|
Perception | 1 | 2011 | 168 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2012 | 435 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2015 | 2818 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2011 | 379 | 0.020 |
Why?
|
Databases, Factual | 1 | 2013 | 814 | 0.020 |
Why?
|
Asbestos | 1 | 2009 | 22 | 0.020 |
Why?
|
Cricetulus | 1 | 2009 | 126 | 0.020 |
Why?
|
Family Health | 1 | 2009 | 162 | 0.020 |
Why?
|
5' Flanking Region | 1 | 2008 | 16 | 0.020 |
Why?
|
Memory | 1 | 2011 | 225 | 0.020 |
Why?
|
Phosphorylation | 1 | 2011 | 1106 | 0.020 |
Why?
|
CHO Cells | 1 | 2009 | 187 | 0.020 |
Why?
|
Jews | 1 | 2008 | 42 | 0.020 |
Why?
|
Death Certificates | 1 | 2008 | 11 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2005 | 1939 | 0.020 |
Why?
|
Lipid Peroxidation | 1 | 2008 | 44 | 0.020 |
Why?
|
Apoptosis | 1 | 2015 | 1683 | 0.020 |
Why?
|
Cricetinae | 1 | 2009 | 560 | 0.020 |
Why?
|
Tritium | 1 | 2007 | 133 | 0.020 |
Why?
|
Nigeria | 1 | 2008 | 152 | 0.020 |
Why?
|
Suppression, Genetic | 1 | 2007 | 30 | 0.020 |
Why?
|
Aflatoxins | 1 | 2007 | 2 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2011 | 1135 | 0.020 |
Why?
|
Reference Values | 1 | 2008 | 674 | 0.020 |
Why?
|
Albumins | 1 | 2007 | 133 | 0.020 |
Why?
|
Korea | 1 | 2005 | 17 | 0.020 |
Why?
|
Fresh Water | 1 | 2005 | 19 | 0.020 |
Why?
|
Signal Transduction | 2 | 2008 | 3241 | 0.020 |
Why?
|
Hypesthesia | 1 | 2005 | 15 | 0.020 |
Why?
|
Toes | 1 | 2005 | 14 | 0.020 |
Why?
|
Hematinics | 1 | 2005 | 11 | 0.020 |
Why?
|
Diet, Vegetarian | 1 | 2005 | 8 | 0.020 |
Why?
|
Base Pair Mismatch | 1 | 2005 | 27 | 0.020 |
Why?
|
Proprioception | 1 | 2005 | 32 | 0.020 |
Why?
|
Hand Strength | 1 | 2005 | 51 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2005 | 102 | 0.020 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2004 | 10 | 0.020 |
Why?
|
Animals, Domestic | 1 | 2004 | 12 | 0.020 |
Why?
|
Micronutrients | 1 | 2004 | 17 | 0.020 |
Why?
|
Child Welfare | 1 | 2004 | 39 | 0.020 |
Why?
|
Cell Line | 1 | 2009 | 2468 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2005 | 214 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 3030 | 0.010 |
Why?
|
Eating | 1 | 2004 | 166 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 526 | 0.010 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2003 | 4 | 0.010 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2003 | 11 | 0.010 |
Why?
|
Seasons | 1 | 2004 | 223 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 636 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 2003 | 274 | 0.010 |
Why?
|
DNA Repair | 1 | 2005 | 356 | 0.010 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2002 | 54 | 0.010 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2002 | 24 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2002 | 147 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 543 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2002 | 157 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2002 | 270 | 0.010 |
Why?
|
HeLa Cells | 1 | 2002 | 498 | 0.010 |
Why?
|
Alternative Splicing | 1 | 2002 | 201 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 1041 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2005 | 1565 | 0.010 |
Why?
|
Prostatic Hyperplasia | 1 | 2002 | 88 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 2002 | 162 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2002 | 378 | 0.010 |
Why?
|